Loading...
Header Logo
Keywords
Last Name
Institution

PATRICK M LYNCH

TitleProfessor
InstitutionMD Anderson
DepartmentGastroenterology Hepatology & Nutrition
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yokoi F, Oleas J, Xing H, Liu Y, Dexter KM, Misztal C, Gerard M, Efimenko I, Lynch P, Villanueva M, Alsina R, Krishnaswamy S, Vaillancourt DE, Li Y. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Neurobiol Dis. 2020 Feb; 134:104638. PMID: 31618684.
      View in: PubMed
    2. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP, Hampel H, Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J, Peter S, Regenbogen SE, Dwyer MA, Ogba N. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019. J Natl Compr Canc Netw. 2019 Sep 01; 17(9):1032-1041. PMID: 31487681.
      View in: PubMed
    3. Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Pande M, Vilar E, You YN, Rodriguez-Bigas MA, Strong LL, Lynch PM, Lu KH, Basen-Engquist K. Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. Fam Cancer. 2019 10; 18(4):399-420. PMID: 31236808.
      View in: PubMed
    4. Delacruz RGC, Sandoval IT, Chang K, Miller BN, Reyes-Uribe L, Borras E, Lynch PM, Taggart MW, Hawk ET, Vilar E, Jones DA. Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas. Oncotarget. 2019 Jun 11; 10(39):3939-3951. PMID: 31231471.
      View in: PubMed
    5. Mork ME, Rodriguez A, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Thirumurthi S, You YN, Vilar E. Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genet. 2019 Jun; 235-236:77-83. PMID: 31101557.
      View in: PubMed
    6. Donato KM, Moore K, Parker WM, Peterson SK, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Burton-Chase AM. Health and lifestyle behaviors in colorectal cancer survivors with and without Lynch syndrome. J Community Genet. 2020 Jan; 11(1):59-63. PMID: 31016603.
      View in: PubMed
    7. Mork M, Quesada PR, Bannon S, Montiel MF, Fleming JB, Lynch PM, Bhutani MS, Lee JH, McAllister F. Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome. Pancreas. 2019 04; 48(4):e29-e30. PMID: 30973470.
      View in: PubMed
    8. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20?mm colon polyps. Endosc Int Open. 2019 Mar; 7(3):E361-E366. PMID: 30834295.
      View in: PubMed
    9. Lee JH, Emelogu I, Kukreja K, Ali FS, Nogueras-Gonzalez G, Lum P, Coronel E, Ross W, Raju GS, Lynch P, Thirumurthi S, Stroehlein J, Wang Y, You YN, Weston B. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc. 2019 07; 90(1):116-124. PMID: 30797835.
      View in: PubMed
    10. Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018; 9:1421. PMID: 30568591.
      View in: PubMed
    11. Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, Peterson SK, You YN, Buchanan DD, Figueiredo JC, Campbell PT, Gallinger S, Newcomb PA, Potter JD, Lindor NM, Le Marchand L, Haile RW, Hopper JL, Jenkins MA, Basen-Engquist KM, Lynch PM, Pande M. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018 11 01; 143(9):2250-2260. PMID: 29904935.
      View in: PubMed
    12. Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018. J Natl Compr Canc Netw. 2018 08; 16(8):939-949. PMID: 30099370.
      View in: PubMed
    13. Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. JAMA Oncol. 2018 08 01; 4(8):1085-1092. PMID: 29710228.
      View in: PubMed
    14. Vallabhaneni H, Lynch PJ, Chen G, Park K, Liu Y, Goehe R, Mallon BS, Boehm M, Hursh DA. High Basal Levels of ?H2AX in Human Induced Pluripotent Stem Cells Are Linked to Replication-Associated DNA Damage and Repair. Stem Cells. 2018 10; 36(10):1501-1513. PMID: 29873142.
      View in: PubMed
    15. Burton-Chase AM, Parker WM, Donato KM, McCormick S, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, Nancy You Y, Peterson SK. Health-related quality of life in colorectal cancer survivors: are there differences between sporadic and hereditary patients? J Patient Rep Outcomes. 2017; 2(1):21. PMID: 29757305.
      View in: PubMed
    16. Pande M, Joon A, Brewster AM, Chen WV, Hopper JL, Eng C, Shete S, Casey G, Schumacher F, Lin Y, Harrison TA, White E, Ahsan H, Andrulis IL, Whittemore AS, John EM, Ko Win A, Makalic E, Schmidt DF, Kapuscinski MK, Ochs-Balcom HM, Gallinger S, Jenkins MA, Newcomb PA, Lindor NM, Peters U, Amos CI, Lynch PM. Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One. 2018; 13(4):e0196245. PMID: 29698419.
      View in: PubMed
    17. Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, Llor X, Chung DC, Ahnen DJ, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Markowitz AJ, Mayer RJ, Ness RM, Samadder NJ, Shike M, Sugandha S, Weiss JM, Dwyer MA, Ogba N. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017. J Natl Compr Canc Netw. 2017 12; 15(12):1465-1475. PMID: 29223984.
      View in: PubMed
    18. Lynch PM. Colorectal Cancer Genetics Screening in the Community: Are We Ready? Can We Do It? Clin Gastroenterol Hepatol. 2018 01; 16(1):21-23. PMID: 28987506.
      View in: PubMed
    19. Borras E, Chang K, Pande M, Cuddy A, Bosch JL, Bannon SA, Mork ME, Rodriguez-Bigas MA, Taggart MW, Lynch PM, You YN, Vilar E. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila). 2017 Oct; 10(10):580-587. PMID: 28765196.
      View in: PubMed
    20. Burke CA, Phillips R, Berger MF, Li C, Essex MN, Iorga D, Lynch PM. Children's International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis. Clin Exp Gastroenterol. 2017; 10:177-185. PMID: 28765715.
      View in: PubMed
    21. Mork ME, Rodriguez A, Taggart MW, Rodriguez-Bigas MA, Lynch PM, Bannon SA, You YN, Vilar E. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer. 2017 07; 16(3):357-361. PMID: 28004223.
      View in: PubMed
    22. Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E. Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis. Clin Cancer Res. 2017 Oct 01; 23(19):5936-5947. PMID: 28645942.
      View in: PubMed
    23. Goldstein JB, Wu W, Borras E, Masand G, Cuddy A, Mork ME, Bannon SA, Lynch PM, Rodriguez-Bigas M, Taggart MW, Wu J, Scheet P, Kopetz S, You YN, Vilar E. Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy? Clin Cancer Res. 2017 Sep 01; 23(17):5246-5254. PMID: 28522602.
      View in: PubMed
    24. Katz LH, Advani S, Burton-Chase AM, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency. Fam Cancer. 2017 04; 16(2):231-237. PMID: 27832499.
      View in: PubMed
    25. Burton-Chase AM, Parker WM, Polivka KM, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, Nancy You Y, Peterson SK. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med. 2017 03; 6(3):698-707. PMID: 28211618.
      View in: PubMed
    26. Sunga AY, Ricker C, Espenschied CR, Castillo D, Melas M, Herzog J, Bannon S, Cruz-Correa M, Lynch P, Solomon I, Gruber SB, Weitzel JN. Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome. Cancer Genet. 2017 04; 212-213:1-7. PMID: 28449805.
      View in: PubMed
    27. Mork ME, Borras E, Taggart MW, Cuddy A, Bannon SA, You YN, Lynch PM, Ramirez PT, Rodriguez-Bigas MA, Vilar E. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency. Fam Cancer. 2016 10; 15(4):587-91. PMID: 27017610.
      View in: PubMed
    28. Cassani LS, Lanke G, Chen HC, Wang X, Lynch P, Lee JH. Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas. Gastrointest Endosc. 2017 Apr; 85(4):803-812. PMID: 27530072.
      View in: PubMed
    29. Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Regenbogen SE, Samadder NJ, Shike M, Steinbach G, Weinberg D, Dwyer M, Darlow S. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 08; 14(8):1010-30. PMID: 27496117.
      View in: PubMed
    30. de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46. PMID: 27432916.
      View in: PubMed
    31. Lynch PM. Chemoprevention of familial adenomatous polyposis. Fam Cancer. 2016 07; 15(3):467-75. PMID: 27083160.
      View in: PubMed
    32. Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E. Genomic Landscape of Colorectal Mucosa and Adenomas. Cancer Prev Res (Phila). 2016 06; 9(6):417-27. PMID: 27221540.
      View in: PubMed
    33. Ricciardiello L, Ahnen DJ, Lynch PM. Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol. 2016 06; 13(6):352-61. PMID: 27095653.
      View in: PubMed
    34. Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK. Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. JAMA. 2016 Mar 22-29; 315(12):1266-75. PMID: 27002448.
      View in: PubMed
    35. Raju GS, Lum PJ, Ross WA, Thirumurthi S, Miller E, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila ML, Stroehlein JR. Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc. 2016 Aug; 84(2):315-25. PMID: 26859866.
      View in: PubMed
    36. Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul; 84(1):115-125.e4. PMID: 26769407.
      View in: PubMed
    37. Guindalini RS, Win AK, Gulden C, Lindor NM, Newcomb PA, Haile RW, Raymond V, Stoffel E, Hall M, Llor X, Ukaegbu CI, Solomon I, Weitzel J, Kalady M, Blanco A, Terdiman J, Shuttlesworth GA, Lynch PM, Hampel H, Lynch HT, Jenkins MA, Olopade OI, Kupfer SS. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. 2015 Nov; 149(6):1446-53. PMID: 26248088.
      View in: PubMed
    38. Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Gupta S, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Rao MS, Regenbogen SE, Shike M, Steinbach G, Weinberg D, Dwyer MA, Freedman-Cass DA, Darlow S. Colorectal Cancer Screening, Version 1.2015. J Natl Compr Canc Netw. 2015 Aug; 13(8):959-68; quiz 968. PMID: 26285241.
      View in: PubMed
    39. Lynch PM. The Case for Universal Testing of Colorectal Tumors for Microsatellite Instability: A Coming Mismatch Between Clinical and Laboratory Testing. Dig Dis Sci. 2015 Aug; 60(8):2225-7. PMID: 26123836.
      View in: PubMed
    40. Mork ME, You YN, Ying J, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Vilar E. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol. 2015 Nov 01; 33(31):3544-9. PMID: 26195711.
      View in: PubMed
    41. Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw. 2015 Jul; 13(7):865-72. PMID: 26150580.
      View in: PubMed
    42. Lynch PJ, Thompson EE, McGinnis K, Rovira Gonzalez YI, Lo Surdo J, Bauer SR, Hursh DA. Chromatin Changes at the PPAR-?2 Promoter During Bone Marrow-Derived Multipotent Stromal Cell Culture Correlate With Loss of Gene Activation Potential. Stem Cells. 2015 Jul; 33(7):2169-81. PMID: 25640287.
      View in: PubMed
    43. Raju GS, Lum PJ, Slack RS, Thirumurthi S, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc. 2015 Sep; 82(3):512-9. PMID: 25910665.
      View in: PubMed
    44. Goodenberger ML, Thomas BC, Riegert-Johnson D, Boland CR, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK, Macrae FA, Lynch HT, Weitzel JN, de la Chapelle A, Syngal S, Lynch P, Parry S, Jenkins MA, Gallinger S, Holter S, Aronson M, Newcomb PA, Burnett T, Le Marchand L, Pichurin P, Hampel H, Terdiman JP, Lu KH, Thibodeau S, Lindor NM. PMS2 monoallelic mutation carriers: the known unknown. Genet Med. 2016 Jan; 18(1):13-9. PMID: 25856668.
      View in: PubMed
    45. Lynch PM, Burke CA, Phillips R, Morris JS, Slack R, Wang X, Liu J, Patterson S, Sinicrope FA, Rodriguez-Bigas MA, Half E, Bulow S, Latchford A, Clark S, Ross WA, Malone B, Hasson H, Richmond E, Hawk E. An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 2016 Feb; 65(2):286-95. PMID: 25792707.
      View in: PubMed
    46. Ross WA, Thirumurthi S, Lynch PM, Rashid A, Pande M, Shafi MA, Lee JH, Raju GS. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards? Gastrointest Endosc. 2015 Mar; 81(3):567-74. PMID: 25583558.
      View in: PubMed
    47. Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet. 2014 Oct-Dec; 207(10-12):495-502. PMID: 25432668.
      View in: PubMed
    48. Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM. Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol. 2014 Oct; 135(1):85-9. PMID: 25149916.
      View in: PubMed
    49. Lynch PM. Colorectal cancer screening in the American Indian/Alaska Native population: progress and at least one new challenge. Cancer. 2014 Oct 15; 120(20):3105-7. PMID: 25123576.
      View in: PubMed
    50. Bannon SA, Mork M, Vilar E, Peterson SK, Lu K, Lynch PM, Rodriguez-Bigas MA, You YN. Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hered Cancer Clin Pract. 2014 Feb 05; 12(1):1. PMID: 24499499.
      View in: PubMed
    51. Borras E, Taggart MW, Lynch PM, Vilar E. Establishing a diagnostic road map for MUTYH-associated polyposis. Clin Cancer Res. 2014 Mar 01; 20(5):1061-3. PMID: 24486588.
      View in: PubMed
    52. Lynch HT, Snyder C, Stacey M, Olson B, Peterson SK, Buxbaum S, Shaw T, Lynch PM. Communication and technology in genetic counseling for familial cancer. Clin Genet. 2014 Mar; 85(3):213-22. PMID: 24355094.
      View in: PubMed
    53. Lynch PM. When and how to perform genetic testing for inherited colorectal cancer syndromes. J Natl Compr Canc Netw. 2013 Dec 01; 11(12):1577-83. PMID: 24335689.
      View in: PubMed
    54. Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Jasperson K, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Dwyer M, Freedman-Cass D. Colorectal cancer screening. J Natl Compr Canc Netw. 2013 Dec 01; 11(12):1538-75. PMID: 24335688.
      View in: PubMed
    55. Burton-Chase AM, Hovick SR, Sun CC, Boyd-Rogers S, Lynch PM, Lu KH, Peterson SK. Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome. Clin Genet. 2014 Aug; 86(2):185-9. PMID: 23906188.
      View in: PubMed
    56. Lynch PM. Colorectal cancer survival by location and microsatellite status: data from the Colon Cancer Family Registries and their implications. Dis Colon Rectum. 2013 Aug; 56(8):935-6. PMID: 23838860.
      View in: PubMed
    57. Lynch HT, Lynch PM. Foreword for "100 years of Lynch syndrome". Fam Cancer. 2013 Jun; 12(2):143-4. PMID: 23661170.
      View in: PubMed
    58. de Vos tot Nederveen Cappel WH, Järvinen HJ, Lynch PM, Engel C, Mecklin JP, Vasen HF. Colorectal surveillance in Lynch syndrome families. Fam Cancer. 2013 Jun; 12(2):261-5. PMID: 23525799.
      View in: PubMed
    59. Lynch HT, Lynch PM. Colorectal cancer: Update on the clinical management of Lynch syndrome. Nat Rev Gastroenterol Hepatol. 2013 Jun; 10(6):323-4. PMID: 23609465.
      View in: PubMed
    60. Wei C, Chen J, Pande M, Lynch PM, Frazier ML. A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome. J Cancer Res Clin Oncol. 2013 Jul; 139(7):1241-50. PMID: 23604467.
      View in: PubMed
    61. Raju GS, Vadyala V, Slack R, Krishna SG, Ross WA, Lynch PM, Bresalier RS, Hawk E, Stroehlein JR. Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med. 2013 Jun; 2(3):391-402. PMID: 23930215.
      View in: PubMed
    62. Lynch PM. Tumor-based screening for hereditary nonpolyposis colorectal cancer: does age-based selection optimize yield? J Oncol Pract. 2013 Jul; 9(4):180-1. PMID: 23942917.
      View in: PubMed
    63. Burton-Chase AM, Hovick SR, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families. Clin Genet. 2013 Mar; 83(3):215-20. PMID: 23414081.
      View in: PubMed
    64. Lynch PM. Cancer risks after endometrial cancer in mismatch repair mutation carriers. J Natl Cancer Inst. 2013 Feb 20; 105(4):251-2. PMID: 23385443.
      View in: PubMed
    65. Lynch PM, Morris JS, Ross WA, Rodriguez-Bigas MA, Posadas J, Khalaf R, Weber DM, Sepeda VO, Levin B, Shureiqi I. Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool. Gastrointest Endosc. 2013 Mar; 77(3):455-63. PMID: 23332604.
      View in: PubMed
    66. Chen J, Pande M, Huang YJ, Wei C, Amos CI, Talseth-Palmer BA, Meldrum CJ, Chen WV, Gorlov IP, Lynch PM, Scott RJ, Frazier ML. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients. Carcinogenesis. 2013 Feb; 34(2):299-306. PMID: 23125224.
      View in: PubMed
    67. Pande M, Wei C, Chen J, Amos CI, Lynch PM, Lu KH, Lucio LA, Boyd-Rogers SG, Bannon SA, Mork ME, Frazier ML. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Fam Cancer. 2012 Sep; 11(3):441-7. PMID: 22714864.
      View in: PubMed
    68. Lynch PM. Current approaches in hereditary nonpolyposis colorectal cancer. J Natl Compr Canc Netw. 2012 Aug; 10(8):961-7. PMID: 22878821.
      View in: PubMed
    69. Ross W, Lynch P, Raju G, Rodriguez A, Burke T, Hafemeister L, Hawk E, Wu X, Dubois RN, Mishra L. Biomarkers, bundled payments, and colorectal cancer care. Genes Cancer. 2012 Jan; 3(1):16-22. PMID: 22893787.
      View in: PubMed
    70. Jaganmohan S, Lynch PM, Raju RP, Ross WA, Lee JE, Raju GS, Bhutani MS, Fleming JB, Lee JH. Endoscopic management of duodenal adenomas in familial adenomatous polyposis--a single-center experience. Dig Dis Sci. 2012 Mar; 57(3):732-7. PMID: 21960285.
      View in: PubMed
    71. Lynch PM. How helpful is age at colorectal cancer onset in finding HNPCC? Dis Colon Rectum. 2011 May; 54(5):515-7. PMID: 21471750.
      View in: PubMed
    72. Lynch PM. How helpful is age at colorectal cancer onset in finding hereditary nonpolyposis colorectal cancer? Clin Gastroenterol Hepatol. 2011 Jun; 9(6):458-60. PMID: 21440092.
      View in: PubMed
    73. Hu P, Lee CW, Xu JP, Simien C, Fan CL, Tam M, Ramagli L, Brown BW, Lynch P, Frazier ML, Siciliano MJ, Coolbaugh-Murphy M. Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations. Ann Clin Lab Sci. 2011; 41(4):321-30. PMID: 22166501.
      View in: PubMed
    74. Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract. 2011 Jan; 7(1):43-7. PMID: 21532810.
      View in: PubMed
    75. Lynch PM. Hyperplastic polyposis: semantics, biology, and endoscopy. Gut. 2010 Aug; 59(8):1019-21. PMID: 20639248.
      View in: PubMed
    76. Lynch PM. Eicosapentaenoic acid and chemoprevention of FAP. Gut. 2010 Jul; 59(7):871-3. PMID: 20581233.
      View in: PubMed
    77. Lynch PM. Pharmacotherapy for inherited colorectal cancer. Expert Opin Pharmacother. 2010 May; 11(7):1101-8. PMID: 20345333.
      View in: PubMed
    78. Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z, Lynch PM, Moyer MP, Wen XF, Wu X. Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature. 2010 Apr 15; 464(7291):1058-61. PMID: 20348907.
      View in: PubMed
    79. Lynch PM, Ayers GD, Hawk E, Richmond E, Eagle C, Woloj M, Church J, Hasson H, Patterson S, Half E, Burke CA. The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol. 2010 Jun; 105(6):1437-43. PMID: 20234350.
      View in: PubMed
    80. Coolbaugh-Murphy MI, Xu JP, Ramagli LS, Ramagli BC, Brown BW, Lynch PM, Hamilton SR, Frazier ML, Siciliano MJ. Microsatellite instability in the peripheral blood leukocytes of HNPCC patients. Hum Mutat. 2010 Mar; 31(3):317-24. PMID: 20052760.
      View in: PubMed
    81. Lynch PJ, Rusche LN. An auxiliary silencer and a boundary element maintain high levels of silencing proteins at HMR in Saccharomyces cerevisiae. Genetics. 2010 May; 185(1):113-27. PMID: 20176978.
      View in: PubMed
    82. Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, Potter JD, Baron JA, Frazier ML, Amos CI. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9. PMID: 20145170.
      View in: PubMed
    83. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton SR, Ismail MK, Jasperson K, Lazenby AJ, Lynch PM, Martin EW, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw. 2010 Jan; 8(1):8-61. PMID: 20064289.
      View in: PubMed
    84. Burton AM, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control. 2010 Apr; 21(4):513-21. PMID: 20012181.
      View in: PubMed
    85. Lynch PM. The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer. Surg Oncol Clin N Am. 2009 Oct; 18(4):611-24. PMID: 19793569.
      View in: PubMed
    86. Chen J, Etzel CJ, Amos CI, Zhang Q, Viscofsky N, Lindor NM, Lynch PM, Frazier ML. Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome. Cancer Causes Control. 2009 Nov; 20(9):1769-77. PMID: 19690970.
      View in: PubMed
    87. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009 Jul; 76(1):1-18. PMID: 19659756.
      View in: PubMed
    88. Pang J, Yu H, Pearson K, Lynch P, Fong C. Comparison of the MMSE and RUDAS cognitive screening tools in an elderly inpatient population in everyday clinical use. Intern Med J. 2009 Jun; 39(6):411-4. PMID: 19580621.
      View in: PubMed
    89. Rusche LN, Lynch PJ. Assembling heterochromatin in the appropriate places: A boost is needed. J Cell Physiol. 2009 Jun; 219(3):525-8. PMID: 19259946.
      View in: PubMed
    90. Fatima N, Chelius D, Luke BT, Yi M, Zhang T, Stauffer S, Stephens R, Lynch P, Miller K, Guszczynski T, Boring D, Greenwald P, Ali IU. Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients. Cancer Genomics Proteomics. 2009 Jan-Feb; 6(1):41-9. PMID: 19451089.
      View in: PubMed
    91. Lynch PJ, Rusche LN. A silencer promotes the assembly of silenced chromatin independently of recruitment. Mol Cell Biol. 2009 Jan; 29(1):43-56. PMID: 18955502.
      View in: PubMed
    92. Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, Frazier ML. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2393-401. PMID: 18768509.
      View in: PubMed
    93. Bailey AA, Bourke MJ, Williams SJ, Walsh PR, Murray MA, Lee EY, Kwan V, Lynch PM. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008 Apr; 40(4):296-301. PMID: 18389448.
      View in: PubMed
    94. Flanagan D, Moore E, Baker S, Wright D, Lynch P. Diabetes care in hospital--the impact of a dedicated inpatient care team. Diabet Med. 2008 Feb; 25(2):147-51. PMID: 18201215.
      View in: PubMed
    95. Hassanein TI, Tofteng F, Brown RS, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007 Dec; 46(6):1853-62. PMID: 17975845.
      View in: PubMed
    96. Salek RM, Colebrooke RE, Macintosh R, Lynch PJ, Sweatman BC, Emson PC, Griffin JL. A metabolomic study of brain tissues from aged mice with low expression of the vesicular monoamine transporter 2 (VMAT2) gene. Neurochem Res. 2008 Feb; 33(2):292-300. PMID: 18041582.
      View in: PubMed
    97. Lynch PM. New issues in genetic counseling of hereditary colon cancer. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 2):6857s-61s. PMID: 18006790.
      View in: PubMed
    98. Rosen LS, Bilchik AJ, Beart RW, Benson AB, Chang KJ, Compton CC, Grothey A, Haller DG, Ko CY, Lynch PM, Nelson H, Stamos MJ, Turner RR, Willett CG. New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 2):6853s-6s. PMID: 18006789.
      View in: PubMed
    99. Lynch HT, Lynch JF, Lynch PM, Attard T. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer. 2008; 7(1):27-39. PMID: 17999161.
      View in: PubMed
    100. Lynch PM. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC. Digestion. 2007; 76(1):68-76. PMID: 17947820.
      View in: PubMed
    101. Patel PR, Mansfield PF, Crane CH, Wu TT, Lee JH, Lynch PM, Morris J, Pisters PW, Feig B, Sunder PK, Izzo JG, Ajani JA. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer. 2007 Sep 01; 110(5):989-95. PMID: 17636525.
      View in: PubMed
    102. Pande M, Chen J, Amos CI, Lynch PM, Broaddus R, Frazier ML. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1753-9. PMID: 17855693.
      View in: PubMed
    103. Lynch PM. Standards of care in diagnosis and testing for hereditary colon cancer. Fam Cancer. 2008; 7(1):65-72. PMID: 17701450.
      View in: PubMed
    104. Lynch HT, Boland CR, Rodriguez-Bigas MA, Amos C, Lynch JF, Lynch PM. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol. 2007 Aug 10; 25(23):3534-42. PMID: 17687158.
      View in: PubMed
    105. Lynch PM. Chemoprevention with special reference to inherited colorectal cancer. Fam Cancer. 2008; 7(1):59-64. PMID: 17680350.
      View in: PubMed
    106. Chen J, Sen S, Amos CI, Wei C, Jones JS, Lynch P, Frazier ML. Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Mol Carcinog. 2007 Apr; 46(4):249-56. PMID: 17219423.
      View in: PubMed
    107. Lynch HT, Lynch JF, Lynch PM. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). J Natl Cancer Inst. 2007 Feb 21; 99(4):261-3. PMID: 17312298.
      View in: PubMed
    108. Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc. 2007 Jan; 65(1):70-6. PMID: 17185082.
      View in: PubMed
    109. Lynch PM, Delano FA, Schmid-Schönbein GW. The primary valves in the initial lymphatics during inflammation. Lymphat Res Biol. 2007; 5(1):3-10. PMID: 17508898.
      View in: PubMed
    110. Lynch PM. Is the demonstration of adenoma reduction with rofecoxib a pyrrhic victory? Gastroenterology. 2006 Dec; 131(6):2003-5. PMID: 17188962.
      View in: PubMed
    111. Lynch HT, Lynch PM. Clinical selection of candidates for mutational testing for cancer susceptibility. Oncology (Williston Park). 2006 Dec; 20(14 Suppl 10):29-34. PMID: 17354515.
      View in: PubMed
    112. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RL, Starkey MP. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res. 2007 Jan 05; 1127(1):127-35. PMID: 17109828.
      View in: PubMed
    113. Peters MG, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart CL, Jacobson JM, Johnson VA, Pollard RB, Rooney JF, Sherman KE, Swindells S, Polsky B. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology. 2006 Nov; 44(5):1110-6. PMID: 17058225.
      View in: PubMed
    114. Colebrooke RE, Humby T, Lynch PJ, McGowan DP, Xia J, Emson PC. Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease. Eur J Neurosci. 2006 Nov; 24(9):2622-30. PMID: 17100850.
      View in: PubMed
    115. Half EE, Lynch PM. Mutated DNA in the stool--does it have a role in colorectal cancer screening? Nat Clin Pract Gastroenterol Hepatol. 2006 Nov; 3(11):594-5. PMID: 17068491.
      View in: PubMed
    116. Lynch HT, Fusaro RM, Lynch PM. Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer. J Invest Dermatol. 2006 Oct; 126(10):2158-9. PMID: 16983324.
      View in: PubMed
    117. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006 Sep 27; 296(12):1507-17. PMID: 17003399.
      View in: PubMed
    118. Glebov OK, Rodriguez LM, Lynch P, Patterson S, Lynch H, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, Denobile J, Soballe P, Gallinger S, Buchbinder A, Gordon G, Hawk E, Kirsch IR. Celecoxib treatment alters the gene expression profile of normal colonic mucosa. Cancer Epidemiol Biomarkers Prev. 2006 Jul; 15(7):1382-91. PMID: 16835340.
      View in: PubMed
    119. Jones JS, Amos CI, Pande M, Gu X, Chen J, Campos IM, Wei Q, Rodriguez-Bigas M, Lynch PM, Frazier ML. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91. PMID: 16702365.
      View in: PubMed
    120. Lynch PM. Current approaches in familial colorectal cancer: a clinical perspective. J Natl Compr Canc Netw. 2006 Apr; 4(4):421-30. PMID: 16569392.
      View in: PubMed
    121. Lynch HT, Boland CR, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet. 2006 Apr; 14(4):390-402. PMID: 16479259.
      View in: PubMed
    122. Lynch PM. Does regular use of aspirin reduce the risk of colorectal cancer? Nat Clin Pract Oncol. 2006 Apr; 3(4):186-7. PMID: 16596142.
      View in: PubMed
    123. Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW, Mayer RJ, Pasche B, Pirruccello SJ, Rajput A, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Winawer SJ. Colorectal Cancer Screening Clinical Practice Guidelines. J Natl Compr Canc Netw. 2006 Apr; 4(4):384-420. PMID: 16569391.
      View in: PubMed
    124. Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2006 Feb; 4(2):156-76. PMID: 16451772.
      View in: PubMed
    125. Zecevic M, Amos CI, Gu X, Campos IM, Jones JS, Lynch PM, Rodriguez-Bigas MA, Frazier ML. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 2006 Jan 18; 98(2):139-43. PMID: 16418517.
      View in: PubMed
    126. Wallace MH, Lynch PM. The current status of chemoprevention in FAP. Fam Cancer. 2006; 5(3):289-94; discussion 295-6. PMID: 16998675.
      View in: PubMed
    127. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman SM. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 2005 Dec 15; 65(24):11486-92. PMID: 16357157.
      View in: PubMed
    128. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer. 2005 Oct 01; 104(7):1349-55. PMID: 16130133.
      View in: PubMed
    129. Jones JS, Gu X, Lynch PM, Rodriguez-Bigas M, Amos CI, Frazier ML. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control. 2005 Aug; 16(6):749-53. PMID: 16049814.
      View in: PubMed
    130. Church J, Berk T, Boman BM, Guillem J, Lynch C, Lynch P, Rodriguez-Bigas M, Rusin L, Weber T. Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease. Dis Colon Rectum. 2005 Aug; 48(8):1528-34. PMID: 15906134.
      View in: PubMed
    131. Robertson SM, Scarsi KK, Postelnick MJ, Lynch P. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review. Pharmacotherapy. 2005 Aug; 25(8):1068-72. PMID: 16207097.
      View in: PubMed
    132. Lynch PJ, Fraser HB, Sevastopoulos E, Rine J, Rusche LN. Sum1p, the origin recognition complex, and the spreading of a promoter-specific repressor in Saccharomyces cerevisiae. Mol Cell Biol. 2005 Jul; 25(14):5920-32. PMID: 15988008.
      View in: PubMed
    133. Lynch HT, Lynch PM. Molecular screening for the Lynch syndrome--better than family history? N Engl J Med. 2005 May 05; 352(18):1920-2. PMID: 15872208.
      View in: PubMed
    134. Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2005 Mar 20; 23(9):1902-10. PMID: 15774782.
      View in: PubMed
    135. Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74. PMID: 15738026.
      View in: PubMed
    136. Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris J, Pisters PW. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol. 2005 Feb 20; 23(6):1237-44. PMID: 15718321.
      View in: PubMed
    137. Pentz RD, Peterson SK, Watts B, Vernon SW, Lynch PM, Koehly LM, Gritz ER. Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information. Genet Test. 2005; 9(3):261-8. PMID: 16225406.
      View in: PubMed
    138. Abraham SC, Park SJ, Cruz-Correa M, Houlihan PS, Half EE, Lynch PM, Wu TT. Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps. Am J Clin Pathol. 2004 Nov; 122(5):740-6. PMID: 15491970.
      View in: PubMed
    139. Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res. 2004 Sep 01; 10(17):5845-9. PMID: 15355915.
      View in: PubMed
    140. Broaddus RR, Lynch PM, Lu KH, Luthra R, Michelson SJ. Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol. 2004 Aug; 17(8):981-9. PMID: 15143336.
      View in: PubMed
    141. Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, Feig B, Myerson R, Nivers R, Cohen DS, Gunderson LL. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004 Jul 15; 22(14):2774-80. PMID: 15254045.
      View in: PubMed
    142. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol. 2004 Jul; 99(7):1258-66. PMID: 15233663.
      View in: PubMed
    143. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004 Jun 01; 100(11):2347-54. PMID: 15160337.
      View in: PubMed
    144. Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):920-7. PMID: 15184247.
      View in: PubMed
    145. Amos CI, Keitheri-Cheteri MB, Sabripour M, Wei C, McGarrity TJ, Seldin MF, Nations L, Lynch PM, Fidder HH, Friedman E, Frazier ML. Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet. 2004 May; 41(5):327-33. PMID: 15121768.
      View in: PubMed
    146. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, Hsu SC, Smith J, Prockop DJ. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther. 2004 May; 9(5):747-56. PMID: 15120336.
      View in: PubMed
    147. Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU. Serum proteomic profiles suggest celecoxib-modulated targets and response predictors. Cancer Res. 2004 Apr 15; 64(8):2904-9. PMID: 15087410.
      View in: PubMed
    148. Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, Zfass A, Wright AR, Iyer RB, Lynch P, Sivak MV, Butler H. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA. 2004 Apr 14; 291(14):1713-9. PMID: 15082698.
      View in: PubMed
    149. Jones JS, Gu X, Campos IM, Lynch PM, Amos CI, Frazier ML. GSTM1 polymorphism does not affect hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):676-8. PMID: 15066938.
      View in: PubMed
    150. Lynch PM, Schmid-Schönbein GW. Literature watch. Parker LH, Schmidt M, Jin S-W, Gray AM, Beis D, Pham T, Frantz G, Paliert S, Hillan K, Stainier DYR, de Sauvage FJ, Ye W. The endothelial-cell-derived secreted factor Egf17 regulates vascular tube formation. Nature 2004; 428(6984):754-758. Lymphat Res Biol. 2004; 2(2):96-100. PMID: 15615491.
      View in: PubMed
    151. Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus. 2004; 17(1):38-43. PMID: 15209739.
      View in: PubMed
    152. Abu-Hamda EM, Hattab EM, Lynch PM. Small bowel tumors. Curr Gastroenterol Rep. 2003 Oct; 5(5):386-93. PMID: 12959719.
      View in: PubMed
    153. Frazier ML, Xi L, Zong J, Viscofsky N, Rashid A, Wu EF, Lynch PM, Amos CI, Issa JP. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 2003 Aug 15; 63(16):4805-8. PMID: 12941799.
      View in: PubMed
    154. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, Lynch H, Gallinger S, Buchbinder A, Gordon G, Hawk E, Kirsch IR. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev. 2003 Aug; 12(8):755-62. PMID: 12917207.
      View in: PubMed
    155. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, Peister A, Wang MY, Prockop DJ. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A. 2003 Mar 04; 100(5):2397-402. PMID: 12606728.
      View in: PubMed
    156. Lynch HT, Cristofaro G, Rozen P, Vasen H, Lynch P, Mecklin JP, St John J. History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer. Fam Cancer. 2003; 2(Suppl 1):3-5. PMID: 14574154.
      View in: PubMed
    157. Wright EP, Kiely MA, Lynch P, Cull A, Selby PJ. Social problems in oncology. Br J Cancer. 2002 Nov 04; 87(10):1099-104. PMID: 12402148.
      View in: PubMed
    158. Esaki M, Matsumoto T, Mizuno M, Kobori Y, Yoshimura R, Yao T, Iida M. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case. Dis Colon Rectum. 2002 Oct; 45(10):1397-402; discussion 1402-6. PMID: 12394442.
      View in: PubMed
    159. Su LK, Kohlmann W, Ward PA, Lynch PM. Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15. Hum Genet. 2002 Jul; 111(1):88-95. PMID: 12136240.
      View in: PubMed
    160. Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002 Jun; 50(6):857-60. PMID: 12010890.
      View in: PubMed
    161. Lynch PM. Screening colonoscopy for family history of colorectal cancer: a growing consensus. Ann Surg Oncol. 2002 Jun; 9(5):425-7. PMID: 12052750.
      View in: PubMed
    162. Howe JR, Shellnut J, Wagner B, Ringold JC, Sayed MG, Ahmed AF, Lynch PM, Amos CI, Sistonen P, Aaltonen LA. Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot. Am J Hum Genet. 2002 May; 70(5):1357-62. PMID: 11920286.
      View in: PubMed
    163. Yao JC, Schnirer II, Reddy S, Chiang S, Najam A, Yu C, Giacco G, Hess K, Rashid A, Xie K, Lynch P, Ajani JA. Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer. 2002; 5(4):208-12. PMID: 12491078.
      View in: PubMed
    164. Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, Frazier ML. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst. 2001 Jul 18; 93(14):1106-8. PMID: 11459873.
      View in: PubMed
    165. Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer. 2001 Jul 15; 92(2):279-86. PMID: 11466680.
      View in: PubMed
    166. Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol. 2001 Apr; 24(2):107-12. PMID: 11319280.
      View in: PubMed
    167. Lynch PM. COX-2 inhibition in clinical cancer prevention. Oncology (Williston Park). 2001 Mar; 15(3 Suppl 5):21-6. PMID: 11301836.
      View in: PubMed
    168. Frazier ML, O'Donnell FT, Kong S, Gu X, Campos I, Luthra R, Lynch PM, Amos CI. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res. 2001 Feb 15; 61(4):1269-71. PMID: 11245417.
      View in: PubMed
    169. Wu G, Wu W, Hegde M, Fawkner M, Chong B, Love D, Su LK, Lynch P, Snow K, Richards CS. Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography. Genet Test. 2001; 5(4):281-90. PMID: 11960572.
      View in: PubMed
    170. Crane CH, Janjan NA, Abbruzzese JL, Curley S, Vauthey J, Sawaf HB, Dubrow R, Allen P, Ellis LM, Hoff P, Wolff RA, Lenzi R, Brown TD, Lynch P, Cleary K, Rich TA, Skibber J. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys. 2001 Jan 01; 49(1):107-16. PMID: 11163503.
      View in: PubMed
    171. Komaki R, Janjan NA, Ajani JA, Lynch PM, Fairweather JS, Raijman I, Blumenshein GR, Ho L, Pisters PW, Feig BW, Walsh GL, Pazdur R. Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors. Oncology (Williston Park). 2000 Dec; 14(12 Suppl 14):34-7. PMID: 11200147.
      View in: PubMed
    172. Precancerous lesions of the digestive tract. The 18th Annual Symposium of the European Cancer Prevention Organization. Maastricht, The Netherlands. 12-14 October 2000. Abstracts. Eur J Cancer Prev. 2000 Dec; 9(6):443-63. PMID: 11263399.
      View in: PubMed
    173. Frazier ML, Su LK, Amos CI, Lynch PM. Current applications of genetic technology in predisposition testing and microsatellite instability assays. J Clin Oncol. 2000 Nov 01; 18(21 Suppl):70S-4S. PMID: 11060331.
      View in: PubMed
    174. Su LK, Barnes CJ, Yao W, Qi Y, Lynch PM, Steinbach G. Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am J Hum Genet. 2000 Sep; 67(3):582-90. PMID: 10924409.
      View in: PubMed
    175. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52. PMID: 10874062.
      View in: PubMed
    176. Brown RL, Pollock AN, Couchman KG, Hodges M, Hutchinson DO, Waaka R, Lynch P, McCarthy TV, Stowell KM. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Hum Mol Genet. 2000 Jun 12; 9(10):1515-24. PMID: 10888602.
      View in: PubMed
    177. Janjan NA, Crane CN, Feig BW, Cleary K, Dubrow R, Curley SA, Ellis LM, Vauthey J, Lenzi R, Lynch P, Wolff R, Brown T, Pazdur R, Abbruzzese J, Hoff PM, Allen P, Brown B, Skibber J. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):713-8. PMID: 10837955.
      View in: PubMed
    178. Lynch P. If aggressive surveillance in hereditary nonpolyposis colorectal cancer is now state of the art, are there any challenges left? Gastroenterology. 2000 May; 118(5):969-71. PMID: 10784597.
      View in: PubMed
    179. Ibrahim NK, Sahin AA, Dubrow RA, Lynch PM, Boehnke-Michaud L, Valero V, Buzdar AU, Hortobagyi GN. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet. 2000 Jan 22; 355(9200):281-3. PMID: 10675076.
      View in: PubMed
    180. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 2000 Jan 15; 60(2):249-52. PMID: 10667569.
      View in: PubMed
    181. Su LK, Steinbach G, Sawyer JC, Hindi M, Ward PA, Lynch PM. Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis. Hum Genet. 2000 Jan; 106(1):101-7. PMID: 10982189.
      View in: PubMed
    182. Lynch PM. Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Cancer. 1999 Dec 01; 86(11 Suppl):2533-9. PMID: 10630179.
      View in: PubMed
    183. Roth S, Sistonen P, Salovaara R, Hemminki A, Loukola A, Johansson M, Avizienyte E, Cleary KA, Lynch P, Amos CI, Kristo P, Mecklin JP, Kellokumpu I, Järvinen H, Aaltonen LA. SMAD genes in juvenile polyposis. Genes Chromosomes Cancer. 1999 Sep; 26(1):54-61. PMID: 10441006.
      View in: PubMed
    184. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol. 1999 Aug; 17(8):2403-11. PMID: 10561303.
      View in: PubMed
    185. Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, Frazier ML. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology. 1999 Aug; 117(2):350-8. PMID: 10419916.
      View in: PubMed
    186. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, McLaughlin PW, Rodriguez MA, Romaguera JE, Sarris AH, Younes A, Luthra R, Manning JT, Johnson CM, Lahoti S, Shen Y, Lee JE, Winn RJ, Genta RM, Graham DY, Cabanillas FF. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999 Jul 20; 131(2):88-95. PMID: 10419446.
      View in: PubMed
    187. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1027-38. PMID: 10421535.
      View in: PubMed
    188. Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, Ajani J, Rich TA, Goswitz MS, Evetts PA, Allen PK, Lynch PM, Skibber JM. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol. 1999 May; 51(2):153-60. PMID: 10435807.
      View in: PubMed
    189. Frazier ML, Sinicrope FA, Amos CI, Cleary KR, Lynch PM, Levin B, Luthra R. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer. Oncol Rep. 1999 May-Jun; 6(3):497-505. PMID: 10203581.
      View in: PubMed
    190. Lin X, Choi JH, Lynch P, Xi L, Wu E, Frazier ML. Reduction in hMSH2 mRNA levels by premature translation termination: implications for mutation screening in hereditary nonpolyposis colorectal cancer. Dig Dis Sci. 1999 Mar; 44(3):553-9. PMID: 10080150.
      View in: PubMed
    191. Lynch HT, Paulson J, Severin M, Lynch J, Lynch P. Failure to diagnose hereditary colorectal cancer and its medicolegal implications: a hereditary nonpolyposis colorectal cancer case. Dis Colon Rectum. 1999 Jan; 42(1):31-5. PMID: 10211517.
      View in: PubMed
    192. Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc. 1998 Aug; 48(2):172-9. PMID: 9717783.
      View in: PubMed
    193. Vernon SW, Gritz ER, Peterson SK, Amos CI, Baile WF, Perz CA, Lynch PM. Design and methodology of a study of psychosocial aspects of genetic testing for hereditary colorectal cancer. Ann N Y Acad Sci. 1997 Dec 29; 833:190-4. PMID: 9616754.
      View in: PubMed
    194. Raijman I, Lynch P. Coated expandable esophageal stents in the treatment of digestive-respiratory fistulas. Am J Gastroenterol. 1997 Dec; 92(12):2188-91. PMID: 9399749.
      View in: PubMed
    195. Raijman I, Siddique I, Lynch P. Does chemoradiation therapy increase the incidence of complications with self-expanding coated stents in the management of malignant esophageal strictures? Am J Gastroenterol. 1997 Dec; 92(12):2192-6. PMID: 9399750.
      View in: PubMed
    196. Amos CI, Bali D, Thiel TJ, Anderson JP, Gourley I, Frazier ML, Lynch PM, Luchtefeld MA, Young A, McGarrity TJ, Seldin MF. Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. Cancer Res. 1997 Sep 01; 57(17):3653-6. PMID: 9288765.
      View in: PubMed
    197. Gilson E. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. JAMA. 1997 Jul 23-30; 278(4):289-90; author reply 290. PMID: 9228429.
      View in: PubMed
    198. Konishi H, Steinbach G, Terry NH, Fujita K, Lee JJ, Ruifrok A, Spaulding D, Lynch PM, Dubin JA, Andreeff M, Goodacre AM, Hattori T, Hittelman WN. S phase determination in intact colonic crypts by histone H3 messenger RNA in situ hybridization and confocal microscopy. Cancer Epidemiol Biomarkers Prev. 1997 Jul; 6(7):531-6. PMID: 9232341.
      View in: PubMed
    199. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 26; 277(12):997-1003. PMID: 9091675.
      View in: PubMed
    200. Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J, Kahn MJ, McTiernan A, Offit K, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 19; 277(11):915-9. PMID: 9062331.
      View in: PubMed
    201. Vernon SW, Gritz ER, Peterson SK, Amos CI, Perz CA, Baile WF, Lynch PM. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol. 1997 Jan; 16(1):73-86. PMID: 9028817.
      View in: PubMed
    202. Yin J, Kong D, Wang S, Zou TT, Souza RF, Smolinski KN, Lynch PM, Hamilton SR, Sugimura H, Powell SM, Young J, Abraham JM, Meltzer SJ. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum Mutat. 1997; 10(6):474-8. PMID: 9401011.
      View in: PubMed
    203. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet. 1996 Nov; 14(3):255-7. PMID: 8896552.
      View in: PubMed
    204. Roubein LD, Lynch P, Glober G, Sinicrope FA. Interobserver variability in endoscopic ultrasonography: a prospective evaluation. Gastrointest Endosc. 1996 Nov; 44(5):573-7. PMID: 8934164.
      View in: PubMed
    205. Patt YZ, Jones DV, Hoque A, Lozano R, Markowitz A, Raijman I, Lynch P, Charnsangavej C. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer. J Clin Oncol. 1996 Aug; 14(8):2311-5. PMID: 8708722.
      View in: PubMed
    206. Jackson MM, Lynch P. Guideline for isolation precautions in hospitals, 1996. Am J Infect Control. 1996 Jun; 24(3):203-6. PMID: 8806999.
      View in: PubMed
    207. Jeon HM, Lynch PM, Howard L, Ajani J, Levin B, Frazier ML. Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer. Hum Mutat. 1996; 7(4):327-33. PMID: 8723682.
      View in: PubMed
    208. Terry NH, Meistrich ML, Roubein LD, Lynch PM, Dubrow RA, Rich TA. Cellular kinetics in rectal cancer. Br J Cancer. 1995 Aug; 72(2):435-41. PMID: 7640229.
      View in: PubMed
    209. Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Cleary KR, Dubrow RA, Levin B, Lynch PM, Meterissian SH, Roubein LD, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys. 1995 Jul 15; 32(4):1025-9. PMID: 7607922.
      View in: PubMed
    210. Jackson MM, Lynch P. Development of a numeric Health Care Worker Risk-Assessment Scale to evaluate potential for blood-borne pathogen exposures. Am J Infect Control. 1995 Feb; 23(1):13-21. PMID: 7762869.
      View in: PubMed
    211. Kim YH, Ajani JA, Ota DM, Lynch P, Roth JA. Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach. Cancer. 1995 Jan 15; 75(2):451-6. PMID: 7812915.
      View in: PubMed
    212. Lynch P. Biology of gastric cancer: gastritis-metaplasia-dysplasia sequence, role of H Pylori, and molecular correlates of tumor progression. J Infus Chemother. 1995; 5(3):93-6. PMID: 8528971.
      View in: PubMed
    213. Ajani JA, Roth JA, Putnam JB, Walsh G, Lynch PM, Roubein LD, Ryan MB, Natrajan G, Gould P. Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction. Eur J Cancer. 1995; 31A(5):665-70. PMID: 7640036.
      View in: PubMed
    214. Nyström-Lahti M, Parsons R, Sistonen P, Pylkkänen L, Aaltonen LA, Leach FS, Hamilton SR, Watson P, Bronson E, Fusaro R, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet. 1994 Oct; 55(4):659-65. PMID: 7942843.
      View in: PubMed
    215. Lynch HT, Drouhard T, Lanspa S, Smyrk T, Lynch P, Lynch J, Vogelstein B, Nyström-Lahti M, Sistonen P, Peltomäki P, et al. Mutation of an mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 1994 Sep 21; 86(18):1417-9. PMID: 8072036.
      View in: PubMed
    216. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst. 1994 Jul 20; 86(14):1086-91. PMID: 7912736.
      View in: PubMed
    217. Lynch PM. Surveillance and treatment of hereditary non-polyposis colorectal cancer. Anticancer Res. 1994 Jul-Aug; 14(4B):1641-6. PMID: 7979200.
      View in: PubMed
    218. Lynch PM. Hereditary nonpolyposis colorectal carcinoma (HNPCC): clinical application of molecular diagnostic testing. Ann Med. 1994 Jun; 26(3):221-8. PMID: 8074841.
      View in: PubMed
    219. Zales VR, Crawford S, Backer CL, Pahl E, Webb CL, Lynch P, Mavroudis C, Benson DW. Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. J Am Coll Cardiol. 1994 Mar 01; 23(3):766-71. PMID: 8113563.
      View in: PubMed
    220. Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, Gelbert L, Thliveris A, Carlson M, Otterud B, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993 Dec 03; 75(5):951-7. PMID: 8252630.
      View in: PubMed
    221. Roubein LD, DuBrow R, David C, Lynch P, Fornage B, Ajani J, Roth J, Levin B. Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction. Endoscopy. 1993 Nov; 25(9):587-91. PMID: 8119209.
      View in: PubMed
    222. Lynch HT, Smyrk TC, Lanspa SJ, Jenkins JX, Lynch PM, Cavalieri J, Lynch JF. Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome. Cancer. 1993 May 01; 71(9):2709-14. PMID: 8385563.
      View in: PubMed
    223. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993 May; 104(5):1535-49. PMID: 8482467.
      View in: PubMed
    224. Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML. Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas. Mol Carcinog. 1993; 7(1):18-20. PMID: 8382068.
      View in: PubMed
    225. Vasen HF, Mecklin JP, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen LB, Cristofaro G, Müller H, Khan PM, et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis Colon Rectum. 1993 Jan; 36(1):1-4. PMID: 8416772.
      View in: PubMed
    226. Wargovich MJ, Isbell G, Shabot M, Winn R, Lanza F, Hochman L, Larson E, Lynch P, Roubein L, Levin B. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology. 1992 Jul; 103(1):92-7. PMID: 1612362.
      View in: PubMed
    227. Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, Lanspa S, Smyrk T, Cavalieri J, Howard L, et al. Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet. 1992 Jul; 51(1):92-100. PMID: 1319115.
      View in: PubMed
    228. Morris L, Lynch PM, Gleason WA, Schauder C, Pinkel D, Duvic M. Blue rubber bleb nevus syndrome: laser photocoagulation of colonic hemangiomas in a child with microcytic anemia. Pediatr Dermatol. 1992 Jun; 9(2):91-4. PMID: 1603744.
      View in: PubMed
    229. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch PM, Jenkins JX, Rouse J, Cavalieri J, Howard L, Lynch J. Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum. 1992 May; 35(5):411-21. PMID: 1314729.
      View in: PubMed
    230. Cats A, De Vries EG, Kleibeuker JH. Proliferation rate in hereditary nonpolyposis colon cancer. J Natl Cancer Inst. 1991 Nov 20; 83(22):1687-9. PMID: 1749023.
      View in: PubMed
    231. Daneker GW, Carlson GW, Hohn DC, Lynch P, Roubein L, Levin B. Endoscopic laser recanalization is effective for prevention and treatment of obstruction in sigmoid and rectal cancer. Arch Surg. 1991 Nov; 126(11):1348-52. PMID: 1720949.
      View in: PubMed
    232. Lynch HT, Smyrk T, Watson P, Lanspa SJ, Boman BM, Lynch PM, Lynch JF, Cavalieri J. Hereditary colorectal cancer. Semin Oncol. 1991 Aug; 18(4):337-66. PMID: 1677781.
      View in: PubMed
    233. Lynch PM, Wargovich MJ, Lynch HT, Palmer C, Lanspa S, Drouhard T, Lynch J. A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. J Natl Cancer Inst. 1991 Jul 03; 83(13):951-4. PMID: 2067038.
      View in: PubMed
    234. Wargovich MJ, Lynch PM, Levin B. Modulating effects of calcium in animal models of colon carcinogenesis and short-term studies in subjects at increased risk for colon cancer. Am J Clin Nutr. 1991 07; 54(1 Suppl):202S-205S. PMID: 2053562.
      View in: PubMed
    235. Roubein LD, David C, DuBrow R, Faintuch J, Lynch P, Fornage B, Levin B. Endoscopic ultrasonography in staging rectal cancer. Am J Gastroenterol. 1990 Oct; 85(10):1391-4. PMID: 2220734.
      View in: PubMed
    236. Lynch HT, Smyrk TC, Lanspa SJ, Lynch PM, Watson P, Strayhorn PC, Bronson EK, Lynch JF, Priluck IA, Appelman HD. Phenotypic variation in colorectal adenoma/cancer expression in two families. Hereditary flat adenoma syndrome. Cancer. 1990 Sep 01; 66(5):909-15. PMID: 2386918.
      View in: PubMed
    237. Lynch HT, Smyrk TC, Lynch PM, Lanspa SJ, Boman BM, Ens J, Lynch JF, Strayhorn P, Carmody T, Cristofaro G. Adenocarcinoma of the small bowel in lynch syndrome II. Cancer. 1989 Nov 15; 64(10):2178-83. PMID: 2804907.
      View in: PubMed
    238. Lynch P, Green L, Jordan PH, Graham DY. Hepatocellular carcinoma metastatic to the stomach presenting as bleeding multiple craterogenic ulcers. Am J Gastroenterol. 1989 Jun; 84(6):653-5. PMID: 2543213.
      View in: PubMed
    239. Bourke SJ, Banham SW, Carter R, Lynch P, Boyd G. Longitudinal course of extrinsic allergic alveolitis in pigeon breeders. Thorax. 1989 May; 44(5):415-8. PMID: 2763241.
      View in: PubMed
    240. Bourke S, Anderson K, Lynch P, Boyd J, King S, Banham S, Boyd G. Chronic simple bronchitis in pigeon fanciers. Relationship of cough with expectoration to avian exposure and pigeon breeders' disease. Chest. 1989 Mar; 95(3):598-601. PMID: 2920588.
      View in: PubMed
    241. Lynch P, Winn RJ. Clinical management of hereditary nonpolyposis colon cancer. High-risk clinics and registries. Hematol Oncol Clin North Am. 1989 Mar; 3(1):75-86. PMID: 2917964.
      View in: PubMed
    242. Lynch HT, Lanspa SJ, Boman BM, Smyrk T, Watson P, Lynch JF, Lynch PM, Cristofaro G, Bufo P, Tauro AV, et al. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. Gastroenterol Clin North Am. 1988 Dec; 17(4):679-712. PMID: 3068137.
      View in: PubMed
    243. Ward JM, Rice JM, Creasia D, Lynch P, Riggs C. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis. 1983 Aug; 4(8):1021-9. PMID: 6872148.
      View in: PubMed
    244. Lynch HT, Lynch PM, Kimberling WJ, Lynch JF. Medical genetics, Huntington's chorea, and legal questions pertaining to autopsy. Am J Med. 1983 Jul; 75(1):157-60. PMID: 6222650.
      View in: PubMed
    245. Lynch HT, Lynch PM, Lynch JF, Danes BS. What is hereditary colon cancer? Prog Clin Biol Res. 1983; 115:3-38. PMID: 6856637.
      View in: PubMed
    246. Lynch PM. Protection of confidentiality and privacy in family studies. Prog Clin Biol Res. 1983; 115:181-98. PMID: 6856634.
      View in: PubMed
    247. Lynch HT, Albano WA, Lynch JF, Lynch PM, Campbell A. Surveillance and management of patients at high genetic risk for ovarian carcinoma. Obstet Gynecol. 1982 May; 59(5):589-96. PMID: 7070730.
      View in: PubMed
    248. Lynch HT, Ruma TA, Albano WA, Lynch JF, Lynch PM. Phenotypic variation in hereditary adenomatosis: unusual tumor spectrum. Dis Colon Rectum. 1982 Apr; 25(3):235-8. PMID: 6121689.
      View in: PubMed
    249. Lynch HT, Albano WA, Recabaren JA, Fain PR, Lynch PM. Survival in hereditary breast and colon cancer. JAMA. 1981 Sep 11; 246(11):1197. PMID: 7265408.
      View in: PubMed
    250. Lynch HT, Albano W, Recerbaren J, Lynch PM, Lynch JF, Elston R. Prolonged survival as a component of a hereditary breast and nonpolyposis colon cancer. Med Hypotheses. 1981 Sep; 7(9):1201-9. PMID: 7289928.
      View in: PubMed
    251. Lynch HT, Lynch PM, Albano WA, Lynch JF. The cancer family syndrome: a status report. Dis Colon Rectum. 1981 May-Jun; 24(4):311-22. PMID: 7238243.
      View in: PubMed
    252. Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med. 1981 Apr; 141(5):607-11. PMID: 7224741.
      View in: PubMed
    253. Fusaro RM, Lynch HT, Pester J, Lynch PM. Torre's syndrome as phenotypic expression of cancer family syndrome. Arch Dermatol. 1980 Sep; 116(9):986-7. PMID: 7416766.
      View in: PubMed
    254. Lynch P, Dargie H, Krikler S, Krikler D. Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Br Med J. 1980 Jul 19; 281(6234):184-7. PMID: 6773613.
      View in: PubMed
    255. Lynch HT, Follett KL, Lynch PM, Albano WA, Mailliard JL, Pierson RL. Family history in an oncology clinic. Implications for cancer genetics. JAMA. 1979 Sep 21; 242(12):1268-72. PMID: 480539.
      View in: PubMed
    256. Lynch HT, Lynch PM. Tumor variation in the cancer family syndrome: ovarian cancer. Am J Surg. 1979 Sep; 138(3):439-42. PMID: 474881.
      View in: PubMed
    257. Lynch HT, Lynch PM, Albano WA, Edney J, Organ CH, Lynch JF. Hereditary cancer: ascertainment and management. CA Cancer J Clin. 1979 Jul-Aug; 29(4):216-32. PMID: 36967.
      View in: PubMed
    258. Lynch HT, Lynch PM. The cancer-family syndrome: a pragmatic basis for syndrome identification. Dis Colon Rectum. 1979 Mar; 22(2):106-10. PMID: 428275.
      View in: PubMed
    259. Lynch HT, Lynch PM, Follett KL, Harris RE. Familial polyposis coli: heterogeneous polyp expression in 2 kindreds. J Med Genet. 1979 Feb; 16(1):1-7. PMID: 38339.
      View in: PubMed
    260. Lynch HT, Guirgis HA, Harris RE, Lynch PM, Lynch JF, Elston RC, Go RC, Kaplan E. Clinical, genetic, and biostatistical progress in the cancer family syndrome. Front Gastrointest Res. 1979; 4:142-50. PMID: 428886.
      View in: PubMed
    261. Lynch HT, Lynch PM, Harris RE. Minimal genetic findings and their cancer control implications. A family with the cancer family syndrome. JAMA. 1978 Aug 11; 240(6):535-8. PMID: 671663.
      View in: PubMed
    262. Lynch HT, Lynch PM. Genetics and cancer in children. Pediatr Ann. 1978 Jun; 7(6):71-83, 87-8, 90 passim. PMID: 209389.
      View in: PubMed
    263. Lynch HT, Bardawil WA, Harris RE, Lynch PM, Guirgis HA, Lynch JF. Multiple primary cancers and prolonged survival: familial colonic and endometrial cancers. Dis Colon Rectum. 1978 Apr; 21(3):165-8. PMID: 274258.
      View in: PubMed
    264. Lynch PM, Lynch HT. Genetic counseling of high-cancer-risk patients: jurisprudential considerations. Semin Oncol. 1978 Mar; 5(1):107-18. PMID: 345449.
      View in: PubMed
    265. Lynch HT, Organ CH, Harris RE, Guirgis HA, Lynch PM, Lynch JF. Familial cancer: implications for surgical management of high-risk patients. Surgery. 1978 Jan; 83(1):104-13. PMID: 339389.
      View in: PubMed
    266. Lynch PM, Lynch HT, Harris RE. Hereditary proximal colonic cancer. Dis Colon Rectum. 1977 Nov-Dec; 20(8):661-8. PMID: 923394.
      View in: PubMed
    267. Lynch HT, Harris RE, Lynch PM, Guirgis HA, Lynch JF, Bardawil WA. Role of heredity in multiple primary cancer. Cancer. 1977 Oct; 40(4 Suppl):1849-54. PMID: 907988.
      View in: PubMed
    268. Lynch HT, Lynch PM, Harris RE. Proximal colon cancer in familial carcinoma of the colon exclusive of familial polyposis coli. Lancet. 1977 Jun 18; 1(8025):1306-7. PMID: 68400.
      View in: PubMed
    269. Lynch HT, Guirgis HA, Lynch PM, Lynch JF, Harris RE. Familial cancer syndromes: a survey. Cancer. 1977 Apr; 39(4 Suppl):1867-81. PMID: 404022.
      View in: PubMed
    270. Lynch HT, Harris RE, Organ CH, Guirgis HA, Lynch PM, Lynch JF, Nelson EJ. The surgeon, genetics, and cancer control: the Cancer Family Syndrome. Ann Surg. 1977 Apr; 185(4):435-40. PMID: 557313.
      View in: PubMed
    271. Lynch HT, Harris RE, Bardawil WA, Lynch PM, Guirgis HA, Swartz MJ, Lynch JF. Management of hereditary site-specific colon cancer. Arch Surg. 1977 Feb; 112(2):170-4. PMID: 836152.
      View in: PubMed
    272. Lynch HT, Terasaki PI, Guirgis HA, Sherard BD, Androsh KL, Harris RE, King MC, Petrakis N, Lynch J, Maloney K, Rankin L, Lynch PM, Elston R, Mulcahy G, Platt R. HLA in breast cancer-prone families and the cancer family syndrome. Prog Clin Biol Res. 1977; 16:149-62. PMID: 905320.
      View in: PubMed
    273. Lynch HT, Harris RE, Guirgis HA, Lynch PM, Maloney K, Rankin L, Lynch J. Early age of onset and familial breast cancer. Lancet. 1976 Sep 18; 2(7986):626-7. PMID: 61359.
      View in: PubMed
    274. Lynch HT, Brodkey FD, Lynch P, Lynch J, Maloney K, Rankin L, Kraft C, Swartz M, Westercamp T, Guirgis HA. Familial risk and cancer control. JAMA. 1976 Aug 09; 236(6):582-4. PMID: 947240.
      View in: PubMed
    275. Lynch PM, Lynch HT. Medical-legal aspects of familial cancer. J Leg Med (N Y). 1976 May; 4(5):10-6. PMID: 1084385.
      View in: PubMed
    276. Lynch HT, Guirgis H, Brodkey F, Maloney K, Lynch PM, Rankin L, Lynch J. Early age of onset in familial breast cancer. Genetic and cancer control implications. Arch Surg. 1976 Feb; 111(2):126-31. PMID: 1252118.
      View in: PubMed
    277. Lynch HT, Mulcahy GM, Lynch P, Guirgis H, Brodkey F, Lynch J, Maloney K, Rankin L. Genetic factors in breast cancer: a survey. Pathol Annu. 1976; 11:77-101. PMID: 794807.
      View in: PubMed
    278. Lynch HT, Brodkey FD, Guirgis HA, Swartz MJ, Lynch JF, Lynch PM. Survival data from a multiphasic mobile cancer detection unit. Oncology. 1976; 33(4):179-82. PMID: 1018882.
      View in: PubMed
    279. Lynch HT, Frichot BC, Lynch P, Lynch J, Gurigis HA. Family studies of malignant melanoma and associated cancer. Surg Gynecol Obstet. 1975 Oct; 141(4):517-22. PMID: 1166375.
      View in: PubMed
    280. Lynch HT, Lynch J, Lynch P. Breast cancer genetics and cancer control. Tumor association. Arch Surg. 1975 Oct; 110(10):1227-9. PMID: 1191014.
      View in: PubMed
    281. Foley GE, Handler AH, Lynch PM, Wolman SR, Stulberg CS, Eagle H. Loss of neoplastic properties in vitro. II. Observations on KB sublines. Cancer Res. 1965 Sep; 25(8):1254-61. PMID: 5839717.
      View in: PubMed
    282. Genetic/familial high-risk assessment. JNCCN Journal of the National Comprehensive Cancer Network. 14:1010-1030.
    283. Palliation of malignant gastric outlet and duodenal obstruction using expandable metallic stents. Gastrointestinal Endoscopy. 47.
    284. Response. Journal of the National Cancer Institute. 83:1688-1689.
    285. Host factors in cancer prevention. Cancer Detection and Prevention. 2:47-64.
    286. Molecular genetics of familial colorectal cancer. Cancer Bulletin. 46:315-321.
    287. Surveillance in hereditary nonpolyposis colorectal cancer. Diseases of the Colon and Rectum. 36:425-429.
    288. Medical/legal issues in genetic testing. Cancer. 80:630-631.
    289. National activities. Anticancer Research. 14:1665-1673.
    290. Hnpcc. Giornale Italiano di Endoscopia Digestiva. 38:271-273.
    291. Endoscopic management of biliary tract cancer with the wallstent. Gastrointestinal Endoscopy. 45.
    292. Comparison between metastatic vs primary biliary tract cancer in their response to the wallstent. Gastrointestinal Endoscopy. 45.
    293. Discussion. Clinical Cancer Research. 13.
    294. Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer. Current Colorectal Cancer Reports. 1:110-116.
    295. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency. Familial Cancer. 1-7.
    296. Familial Cancer. 1-5.
    297. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Clinical Genetics. 89:392-398.
    298. Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointestinal Endoscopy.
    299. Palliation of malignant colorectal strictures with expandable metallic stents. Gastrointestinal Endoscopy. 47.
    300. Familial Clustering of Plasma Carcinoembryonic Antigen (CEA) in the Cancer Family Syndrome. Scandinavian Journal of Immunology. 8:465-470.
    301. Palliation of malignant dysphagia and fistulae with the Wwallstent. Gastrointestinal Endoscopy. 45.
    302. Colon cancer. 77-84.
    303. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointestinal Endoscopy.
    304. DNA Mismatch Repair Deficiency in Rectal Cancer. Journal of Clinical Oncology. 34:3039-3046.
    305. Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer. Cancer Research Therapy and Control. 8:35-49.
    306. Mutation Spectrum and Risk of Colorectal Cancer in African American Families with Lynch Syndrome. Gastroenterology. 149:1446-1453.
    307. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. Journal of Clinical Oncology. 33:3544-3549.
    308. FIFTH INTERNATIONAL CONGRESS OF HUMAN GENETICS.
    309. Family History in an Oncology Clinic. JAMA - Journal of the American Medical Association. 242:1268-1272.
    310. Palliation of malignant dysphagia with chemoradiation therapy (ChXRT) does not increase the rate of serious complications with coated Wallstent. Gastrointestinal Endoscopy. 45.
    311. PMS2 monoallelic mutation carriers. Genetics in Medicine. 18:13-19.
    312. Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas. Gastrointestinal Endoscopy.
    313. Benefits and Risks of Screening Mammography in Women With BRCA1 and BRCA2 Mutations-Reply. JAMA - Journal of the American Medical Association. 278:290.
    314. FIFTH INTERNATIONAL CONGRESS OF HUMAN GENETICS.
    315. The role of aspirin in the Prevention of polyp recurrence. Current Colorectal Cancer Reports. 3:24-28.
    316. Management of malignant colorectal strictures with expandable endoprosthesis. Gastrointestinal Endoscopy. 45.
    317. Tumor factors that may affect the outcome after palliation with the esophageal Wallstent?. Gastrointestinal Endoscopy. 45.
    318. The role of genetics and host factors in cancer susceptibility and cancer resistance. Cancer Detection and Prevention. 1:175-224.
    319. Medicolegal Aspects of Endoscopic Screening and Genetic Testing in Hereditary Colon Cancer Syndromes. Techniques in Gastrointestinal Endoscopy. 8:133-139.
    320. Patient-reported disease knowledge and educational needs in Lynch syndrome. Hereditary Cancer in Clinical Practice. 12.
    321. Historical development of Lynch syndrome. 1-24.
    322. Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Cancer. 86:1713-1719.
    323. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency. Familial Cancer. 1-5.
    324. Management of digestive-respiratory fistulae (DRF) with coated expandable esophageal stents (cEES). Gastrointestinal Endoscopy. 43:343.
    325. The overall complication rate after esophageal Wallstent is related to the esophageal location of the lesion. Gastrointestinal Endoscopy. 45.
    326. Computed tomographic colonography. Evidence-Based Gastroenterology. 5:84-85.
    327. Screening guidelines for colorectal cancer. Cancer Bulletin. 46:359-364.
    328. Management of a rectovesical malignant fistula with the coated wallstent. Gastrointestinal Endoscopy. 45.
    329. Discussion. Clinical Cancer Research. 13.
    330. Chemoprevention of familial adenomatous polyposis. Familial Cancer. 1-9.
    331. Colorectal cancer screening. JNCCN Journal of the National Comprehensive Cancer Network. 8:8-60.
    332. Does chemo-radiation therapy (ChXRT) increase the incidence of complications after self-expanding coated stents (cEES) in the management of malignant esophageal strictures?. Gastrointestinal Endoscopy. 43:343.
    333. Genomic landscape of colorectal mucosa and adenomas. Cancer Prevention Research. 9:417-427.
    334. Does the response to plastic stent(PS) predict that of wallstent(WS) in the treatment of malignant biliary obstruction(MBO)?. Gastrointestinal Endoscopy. 47.
    335. Chemoprevention of hereditary colon cancers. Nature Reviews Gastroenterology and Hepatology. 13:352-361.
    336. How much luminal dilation (if any) is necessary prior to placement of an esophageal Wallstent?. Gastrointestinal Endoscopy. 45.
    337. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointestinal Endoscopy.
    LYNCH's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description